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A 32-year-old, gravida 2, para 1, woman was referred to
the hospital at 23 weeks of gestation because of fetal
cardiac abnormalities detected by sonography. The
woman and her husband were non-consanguineous
and healthy, and there was no family history of congeni-
tal heart defects. The woman had a cousin who suffered
from mental retardation and Down syndrome. Level II
ultrasound revealed a singleton fetus with a fetal biome-
try equivalent to 23 weeks of gestation and a ventricu-
lar septal defect. Amniocentesis was performed, and
36 mL of amniotic fluid was aspirated. About 20 mL of
amniotic fluid was used for array comparative genomic
hybridization (aCGH) using uncultured amniocytes,
and 15 mL was used for conventional cytogenetic analy-
sis using cultured amniocytes. Within 3 days, bacterial
artificial chromosome (BAC)-based aCGH showed tri-
somy 21 [arr cgh 21p11.2q22.3 (RP11-430M17
RP11-1000I21)×3] (Figure 1A). Fluorescence in situ hy-
bridization (FISH) analysis of the cultured interphase
amniocytes using a combination of BAC probes RP11-
135B17 (21q22.3) (47,931,911-48,108,188) (spectrum
green) and RP11-450H16 (13q34) (114,940,140-
115,099,262) (spectrum red) showed three green 
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Figure 1. Bacterial artificial chromosome (BAC)-based array com-
parative genomic hybridization analyses using CMDX (CMDX,
Irvine, CA, USA) BAC array comparative genomic hybridiza-
tion CA3000 chips. (A) Case 1 and (B) Case 2 showed dupli-
cations of chromosome 21 consistent with the diagnosis of
trisomy 21.
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signals and two red signals, consistent with the diag-
nosis of trisomy 21 (Figure 2A). Eight days after amnio-
centesis, conventional cytogenetic analysis revealed a
47,XX,+21 karyotype. Polymorphic DNA marker analysis
using quantitative fluorescence polymerase chain reac-
tion (QF-PCR) showed that the trisomy 21 in this fetus
was likely to have been caused by paternal meiosis II
nondisjunction or postzygotic mitotic nondisjunction
(Figure 3).
A 33-year-old, gravida 2, para 1, woman was re-
ferred to the hospital at 30 weeks of gestation because
of fetal brain abnormalities detected by sonography.
The woman and her husband were non-consanguineous
and healthy, and there was no family history of con-
genital anomalies. Level II ultrasound revealed a single-
ton fetus with a fetal biometry equivalent to 31 weeks
of gestation and bilateral ventriculomegaly with a right
ventricular width of 1.7 cm and a left ventricular width of
1.3 cm. Amniocentesis was performed, and 40 mL of
amniotic fluid was aspirated. About 20 mL of amniotic
fluid was used for aCGH using uncultured amniocytes,
and 20mL was used for conventional cytogenetic analysis
using cultured amniocytes. Within 3 days, BAC-based
aCGH showed trisomy 21 [arr cgh 21p11.2q22.3 (RP11-
1144F24RP11-1000I21)×3] (Figure 1B). FISH (Figure
2B) and QF-PCR (Figure 4) analyses using cultured
amniocytes revealed results consistent with trisomy 21.
Thirteen days after amniocentesis, conventional cyto-
genetic analysis revealed a 47,XX,+21 karyotype. The
parental DNA was not available. According to poly-
morphic DNA marker analysis, trisomy 21 in this 
fetus was likely to have been caused by meiosis I
nondisjunction.
We have previously described the prenatal diagnosis
of aneuploidy by aCGH using cultured or uncultured
amniocytes [1,2]. The current cases further demon-
strated that amniocentesis for genome-wide analysis
using uncultured amniocytes and aCGH is a useful alter-
native to cordocentesis for rapid aneuploidy diagno-
sis in pregnancies with abnormal ultrasound findings
detected during the late second and third trimesters.
Amniocentesis is simpler and less invasive than cor-
docentesis. The fetal loss rate is 0.5% for amniocente-
sis [3,4], compared with 0.8–2.5% for cordocentesis
[5–8]. Cordocentesis is an invasive procedure associ-
ated with risks such as fetal loss, fetal bleeding and
hemorrhage, fetal bradycardia, fetomaternal trans-
fusion, umbilical cord thrombosis and hemorrhage, 
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Figure 2. Fluorescence in situ hybridization analyses of inter-
phase amniocytes using bacterial artificial chromosome
probes RP11-135B17 (21q22.3) (spectrum green) and RP11-
450H16 (13q34) (spectrum red). (A) Case 1 and (B) Case 2
showed three green signals and two red signals, consistent with
the diagnosis of trisomy 21.
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Figure 3. Representative electrophoretogram of quantitative
fluorescence polymerase chain reaction assays in Case 1 at
short tandem repeat markers for chromosome 21q. Two
peaks (250 bp and 266 bp) of unequal fluorescence activity
from different parental alleles (maternal:paternal) at a ratio
of 1:2 were detected in the cultured fetal tissues using the
marker D21S1443. This indicated a homologous duplica-
tion of chromosome 21q of paternal origin and was likely to
be the result of meiosis II nondisjunction or postzygotic
mitotic nondisjunction.
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Figure 4. Representative electrophoretogram of quantitative
fluorescence polymerase chain reaction assays of Case 2 at
short tandem repeat markers for chromosome 21q. Three
peaks (116 bp, 124 bp and 132 bp) of equal fluorescence activ-
ity at a ratio of 1:1:1 were detected in the cultured amniocytes.
This indicated a heterologous duplication of chromosome
21q and was likely to be the result of meiosis I nondisjunction.
The parental DNA was not available.
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infection, abruptio placentae, and premature labor, even
when performed in expert centers [9]. However, cordo-
centesis is preferable to amniocentesis for conventional
cytogenetic analysis, especially in the late second and
third trimesters, because it requires less time for cell cul-
ture. Fetal karyotypes can be obtained by culture of fetal
cord blood lymphocytes from cordocentesis in 2–4 days.
However, rapid karyotyping by cordocentesis has been
replaced by amniocentesis combined with FISH or QF-
PCR [10–15]. FISH and QF-PCR results can be obtained
in 24–48 hours, but can detect only specific aneuploi-
dies according to the specific probes or primers used.
Recently, aCGH using cultured or uncultured amnio-
cytes has been successfully applied for the prenatal diag-
nosis of chromosome abnormalities [16–27]. aCGH
can detect unbalanced structural and numerical chro-
mosome abnormalities of less than 100 kb, whereas
conventional cytogenetic analysis can detect only micro-
scopically visible deletions or duplications of 5–6 Mb
at the 500-band level [25]. Tyreman et al [26] found
that high-resolution array testing would benefit at least
10% of obstetric patients with abnormal ultrasound
findings and a normal karyotype result. aCGH has the
advantage of providing a rapid genome-wide study
without the need for cell culture. However, aCGH also
has the disadvantage of being unable to detect balanced
translocations, inversions or polyploidy. Detection of
low-level mosaicism depends on the dynamic range of
the array used, and several studies have shown that
aCGH can detect low-level mosaicism not revealed 
by conventional cytogenetics [25,28–30]. We, there-
fore, suggest that in a addition to rapid karyotyping by
aCGH, conventional cytogenetic analysis is still required
to rule out the presence of balanced translocations, in-
versions and polyploidy.
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